ÂÜÀòÂÒÂ×

The Leadership Team at Outlook Therapeutics is responsible for guiding the strategic direction of the company, overseeing the development and commercialization of ONS-5010 / LYTENAVAâ„¢. Comprising key executives such as the President & CEO, Chief Commercial Officer, CFO, and COO, this team collaborates to ensure operational excellence, drive financial growth, and navigate regulatory pathways to bring innovative treatments for retinal diseases to market.